Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries

Even for centrally approved products, each European country is responsible for the effective national market access. This step can result in inequalities in terms of access, due to different opinions about the therapeutic value assessed by health technology assessment (HTA) bodies. Advanced therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gozzo, Lucia, Romano, Giovanni Luca, Romano, Francesca, Brancati, Serena, Longo, Laura, Vitale, Daniela Cristina, Drago, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531540/
https://www.ncbi.nlm.nih.gov/pubmed/34690785
http://dx.doi.org/10.3389/fphar.2021.755052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531540/
https://www.ncbi.nlm.nih.gov/pubmed/34690785
http://dx.doi.org/10.3389/fphar.2021.755052

Ejemplares similares